Telmitwin Tablet 80/5 mg

Adult dose

The recommended dosage of this drug is one tablet once daily, to be taken with water, regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning). For patients with renal impairment, dose adjustment is not necessary for mild to moderate renal impairment, while patients with severe renal impairment should start with a lower dose and gradually increase the dosage. For patients with hepatic impairment, the daily dosage should not exceed 40 mg.

Child dose

Safety and efficacy in pediatric patients under the age of 18 have not been established, so administration of this drug is not recommended.

This drug may pose serious risks to the fetus, especially during the second and third trimesters of pregnancy, so women who are pregnant or may become pregnant should not use it. This drug is contraindicated in patients with certain diseases. For example, patients with cholestatic diseases, severe liver impairment, severe hypotension, cardiogenic shock, or unstable blood flow after acute myocardial infarction should not take this medication. Additionally, individuals allergic to the main ingredient or similar medications, and nursing mothers should also avoid using this drug. Patients with primary aldosteronism, aortic or mitral stenosis, liver impairment, gastrointestinal diseases, renal artery hypertension, dialysis patients, elderly patients, etc., require special caution when using this drug. Common side effects such as dizziness or peripheral edema may occur while using this medication, and rarely, fainting or heart-related adverse reactions may also occur. This drug can interact with other medications, so if you are taking other drugs, be sure to consult a doctor or pharmacist. Pregnant women should not use this drug, and if pregnancy is confirmed, immediate discontinuation and seeking alternative treatment is necessary. Symptoms of low blood pressure may occur, so patients, especially those with fluids or salt deficiency, should be cautious. Due to the risk of hyperkalemia, it is important to regularly check potassium levels in the blood. Patients with decreased renal function should also periodically monitor renal function while using this drug. This drug may cause drowsiness or dizziness while driving or operating machinery, so caution is required. In case of overdose, symptoms such as blood pressure drops and heart function abnormalities may appear, necessitating immediate treatment. Finally, keep this product out of the reach of children, and it is recommended to unwrap the package just before use.

Serious side effects

• Urticaria
• angioedema
• severe swelling
• severe allergic reactions
• Stevens-Johnson syndrome
• vasculitis
• liver dysfunction
• hepatic impairment
• hepatitis
• jaundice

Mild side effects

• Dizziness
• peripheral edema
• upper respiratory tract infections
• urinary tract infections
• anemia
• hyperkalemia
• depression
• insomnia
• headache
• drowsiness

This drug is sensitive to light and should be stored in a container that does not allow light to enter. Additionally, it is important to maintain the storage temperature between 1 degree Celsius and 30 degrees Celsius to preserve the effectiveness of the medication over time.

Appearance

This is a white and light gray, biconvex, oval-shaped double-layer tablet.

Package unit

30 tablets/PTP [(10 tablets/PTP x 3)]